Skip to content

Intermittent vs Continous infusion of colistin in VAP

To compare the efficacy of standard intermittent dose regime and continous infusion of intravenous colistin in the treatment of ventilator associated pneumonia in PICU patients - A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018847
Enrollment
150
Registered
2019-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J159- Unspecified bacterial pneumonia

Interventions

Intervention1: Use of 2 different modes of administration of an antibiotic and compare the efficacy.: Use of Colistin in gram negative Ventilator Associated Pneumonia as Intermittent dosing regime. Co

Sponsors

dr simranpreet singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children of age 1 month to 18yrs suffering from VAP as per CPIS score and microbiological evidence of gram negative organism in culture specimen

Exclusion criteria

Exclusion criteria: any patient with gram positive organism growth or sensitivity to a lower class of antibiotic. Also patients who leave against medical advice or those with untimely mortality during study duration

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of intermittent dose regime and continuous infusion of intravenous colistin in terms of clinical and microbiological outcome in the treatment of children with ventilator associated pneumonia.Timepoint: Negative CPIS scores and microbiological clearance documentation in the diagnostic specimen at day 4 or day 7 of treatment whichever applicable

Secondary

MeasureTime frame
1. To study any difference in incidence of adverse effects of colistin when given by either of these methodsTimepoint: Negative CPIS scores and microbiological clearance documentation in the diagnostic specimen on day 4 or day 7 of treatment whichever applicable

Countries

India

Contacts

Public ContactDR SIMRANPREET SINGH

PICU incharge. Sir gangaram hospital

anilcriticare@gmail.com9810098360

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026